BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 25930247)

  • 21. Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.
    Howard-McNatt M; Schroll RW; Hurt GJ; Levine EA
    Am J Surg; 2011 Sep; 202(3):298-302. PubMed ID: 21871984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
    Terkelsen T; Rønning H; Skytte AB
    Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
    [No Abstract]   [Full Text] [Related]  

  • 23. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
    Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Demsky R; Mancuso T; Sun P; Narod SA
    Ann Surg Oncol; 2021 Sep; 28(9):4967-4973. PubMed ID: 33761021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
    Chiba A; Hoskin TL; Hallberg EJ; Cogswell JA; Heins CN; Couch FJ; Boughey JC
    Ann Surg Oncol; 2016 Oct; 23(10):3232-8. PubMed ID: 27338744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in Sexual Function After Breast Cancer Surgery.
    Cornell LF; Mussallem DM; Gibson TC; Diehl NN; Bagaria SP; McLaughlin SA
    Ann Surg Oncol; 2017 Sep; 24(9):2526-2538. PubMed ID: 28560595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
    Yi M; Hunt KK; Arun BK; Bedrosian I; Barrera AG; Do KA; Kuerer HM; Babiera GV; Mittendorf EA; Ready K; Litton J; Meric-Bernstam F
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1026-34. PubMed ID: 20647335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
    Tynan M; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill SC; Jandorf L; Kelly SP; Heinzmann J; Kelleher S; Poggi E; Schwartz MD
    Breast Cancer Res Treat; 2020 Feb; 180(1):177-185. PubMed ID: 31894446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women's decision-making roles regarding contralateral prophylactic mastectomy.
    Nekhlyudov L; Bower M; Herrinton LJ; Altschuler A; Greene SM; Rolnick S; Elmore JG; Harris EL; Liu A; Emmons KM; Fletcher SW; Geiger AM
    J Natl Cancer Inst Monogr; 2005; (35):55-60. PubMed ID: 16287886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral Mastectomy as Overtreatment for Breast Cancer in Women Age Forty Years and Younger with Unilateral Operable Invasive Breast Cancer.
    Donovan CA; Bao J; Gangi A; Amersi F; Zhang X; Giuliano AE; Chung AP
    Ann Surg Oncol; 2017 Aug; 24(8):2168-2173. PubMed ID: 28417238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Receptor Status on Mastectomy and Contralateral Prophylactic Mastectomy Rates in Early Stage Invasive Breast Carcinoma.
    Dutta SW; Trifiletti DM; Grover S; Romano KD; Janowski EM; Showalter SL
    Clin Breast Cancer; 2018 Apr; 18(2):121-127. PubMed ID: 28811185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
    Pesce CE; Liederbach E; Czechura T; Winchester DJ; Yao K
    J Am Coll Surg; 2014 Jul; 219(1):19-28. PubMed ID: 24862886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
    Rosenberg SM; Tracy MS; Meyer ME; Sepucha K; Gelber S; Hirshfield-Bartek J; Troyan S; Morrow M; Schapira L; Come SE; Winer EP; Partridge AH
    Ann Intern Med; 2013 Sep; 159(6):373-81. PubMed ID: 24042365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors Affecting Choice of Treatment for Early-Stage Breast Cancer in West Virginia: A 10-Year Experience from a Rural Tertiary Care Center.
    Suggs PD; Holliday TL; Thompson SN; Richmond BK
    Am Surg; 2017 Jul; 83(7):709-716. PubMed ID: 28738940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
    Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
    Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
    Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast conservative surgery and local recurrence.
    Rezai M; Kraemer S; Kimmig R; Kern P
    Breast; 2015 Nov; 24 Suppl 2():S100-7. PubMed ID: 26432359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.
    Anderson C; Islam JY; Elizabeth Hodgson M; Sabatino SA; Rodriguez JL; Lee CN; Sandler DP; Nichols HB
    Ann Surg Oncol; 2017 Jun; 24(6):1499-1506. PubMed ID: 28058563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.